Apart from its effects similar to SGLT-2 inhibitors, which are currently unconfirmed, and its ability to regulate neurotransmitter pathways, emodin also addresses the other six causes of T2DM. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.